The immune cell landscape in kidneys of patients with lupus nephritis.


Journal

Nature immunology
ISSN: 1529-2916
Titre abrégé: Nat Immunol
Pays: United States
ID NLM: 100941354

Informations de publication

Date de publication:
07 2019
Historique:
received: 18 04 2018
accepted: 05 04 2019
pubmed: 19 6 2019
medline: 10 7 2019
entrez: 19 6 2019
Statut: ppublish

Résumé

Lupus nephritis is a potentially fatal autoimmune disease for which the current treatment is ineffective and often toxic. To develop mechanistic hypotheses of disease, we analyzed kidney samples from patients with lupus nephritis and from healthy control subjects using single-cell RNA sequencing. Our analysis revealed 21 subsets of leukocytes active in disease, including multiple populations of myeloid cells, T cells, natural killer cells and B cells that demonstrated both pro-inflammatory responses and inflammation-resolving responses. We found evidence of local activation of B cells correlated with an age-associated B-cell signature and evidence of progressive stages of monocyte differentiation within the kidney. A clear interferon response was observed in most cells. Two chemokine receptors, CXCR4 and CX3CR1, were broadly expressed, implying a potentially central role in cell trafficking. Gene expression of immune cells in urine and kidney was highly correlated, which would suggest that urine might serve as a surrogate for kidney biopsies.

Identifiants

pubmed: 31209404
doi: 10.1038/s41590-019-0398-x
pii: 10.1038/s41590-019-0398-x
pmc: PMC6726437
mid: NIHMS1526529
doi:

Substances chimiques

Biomarkers 0
Interferons 9008-11-1

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

902-914

Subventions

Organisme : NIAMS NIH HHS
ID : UH2 AR067685
Pays : United States
Organisme : NIAMS NIH HHS
ID : UM2 AR067678
Pays : United States
Organisme : NHGRI NIH HHS
ID : T32 HG002295
Pays : United States
Organisme : NIAMS NIH HHS
ID : UH2 AR067681
Pays : United States
Organisme : NIAMS NIH HHS
ID : UH2 AR067688
Pays : United States
Organisme : NIAMS NIH HHS
ID : UH2 AR067689
Pays : United States
Organisme : NIAMS NIH HHS
ID : UH2 AR067690
Pays : United States
Organisme : NIAMS NIH HHS
ID : UH2 AR067694
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK081943
Pays : United States
Organisme : NIAMS NIH HHS
ID : UH2 AR067679
Pays : United States
Organisme : NHGRI NIH HHS
ID : U01 HG009379
Pays : United States
Organisme : NIAMS NIH HHS
ID : UH2 AR067677
Pays : United States
Organisme : NIAMS NIH HHS
ID : UH2 AR067676
Pays : United States
Organisme : NIAMS NIH HHS
ID : UH2 AR067691
Pays : United States

Investigateurs

Arnon Arazi (A)
Deepak A Rao (DA)
Celine C Berthier (CC)
Anne Davidson (A)
Yanyan Liu (Y)
Paul J Hoover (PJ)
Adam Chicoine (A)
Thomas M Eisenhaure (TM)
A Helena Jonsson (AH)
Shuqiang Li (S)
David J Lieb (DJ)
Fan Zhang (F)
Kamil Slowikowski (K)
Edward P Browne (EP)
Akiko Noma (A)
Danielle Sutherby (D)
Scott Steelman (S)
Dawn E Smilek (DE)
Patti Tosta (P)
William Apruzzese (W)
Elena Massarotti (E)
Maria Dall'Era (M)
Meyeon Park (M)
Diane L Kamen (DL)
Richard A Furie (RA)
Fernanda Payan-Schober (F)
William F Pendergraft (WF)
Elizabeth A McInnis (EA)
Jill P Buyon (JP)
Michelle A Petri (MA)
Chaim Putterman (C)
Kenneth C Kalunian (KC)
E Steve Woodle (ES)
James A Lederer (JA)
David A Hildeman (DA)
Chad Nusbaum (C)
Soumya Raychaudhuri (S)
Matthias Kretzler (M)
Jennifer H Anolik (JH)
Michael B Brenner (MB)
David Wofsy (D)
Nir Hacohen (N)
Betty Diamond (B)
Dia Waguespack (D)
Sean M Connery (SM)
Maureen A McMahon (MA)
William J McCune (WJ)
Ruba B Kado (RB)
Raymond Hsu (R)
Melissa A Cunningham (MA)
Paul J Utz (PJ)
Mina Pichavant (M)
Holden T Maecker (HT)
Rohit Gupta (R)
Judith A James (JA)
Joel M Guthridge (JM)
Chamith Fonseka (C)
Evan Der (E)
Robert Clancy (R)
Thomas Tuschl (T)
Hemant Suryawanshi (H)
Andrea Fava (A)
H Michael Belmont (HM)
Peter M Izmirly (PM)
Pavel Morozov (P)
Manjunath Kustagi (M)
Daniel H Goldman (DH)

Commentaires et corrections

Type : CommentIn
Type : ErratumIn

Références

Costenbader, K. H. et al. Trends in the incidence, demographics, and outcomes of end-stage renal disease due to lupus nephritis in the US from 1995 to 2006. Arthritis Rheum. 63, 1681–1688 (2011).
doi: 10.1002/art.30293
Narain, S. & Furie, R. Update on clinical trials in systemic lupus erythematosus. Curr. Opin. Rheumatol. 28, 477–487 (2016).
doi: 10.1097/BOR.0000000000000311
Tektonidou, M. G., Dasgupta, A. & Ward, M. M. Risk of end-stage renal disease in patients with lupus nephritis, 1971–2015: a systematic review and Bayesian meta-analysis. Arthritis Rheumatol. 68, 1432–1441 (2016).
doi: 10.1002/art.39594
Thanou, A. & Merrill, J. T. Treatment of systemic lupus erythematosus: new therapeutic avenues and blind alleys. Nat. Rev. Rheumatol. 10, 23–34 (2014).
doi: 10.1038/nrrheum.2013.145
Banchereau, R. et al. Personalized immunomonitoring uncovers molecular networks that stratify lupus patients. Cell 165, 1548–1550 (2016).
doi: 10.1016/j.cell.2016.05.057
Liarski, V. M. et al. Cell distance mapping identifies functional T follicular helper cells in inflamed human renal tissue. Sci. Transl. Med. 6, 230ra246 (2014).
doi: 10.1126/scitranslmed.3008146
Hutloff, A. et al. Involvement of inducible costimulator in the exaggerated memory B cell and plasma cell generation in systemic lupus erythematosus. Arthritis Rheum. 50, 3211–3220 (2004).
doi: 10.1002/art.20519
Kassianos, A. J. et al. Increased tubulointerstitial recruitment of human CD141(hi) CLEC9A(+) and CD1c(+) myeloid dendritic cell subsets in renal fibrosis and chronic kidney disease. Am. J. Physiol. Renal Physiol. 305, F1391–F1401 (2013).
doi: 10.1152/ajprenal.00318.2013
Davidson, A. What is damaging the kidney in lupus nephritis? Nat. Rev. Rheumatol. 12, 143–153 (2016).
doi: 10.1038/nrrheum.2015.159
Hashimshony, T. et al. CEL-Seq2: sensitive highly-multiplexed single-cell RNA-Seq. Genome Biol. 17, 77 (2016).
doi: 10.1186/s13059-016-0938-8
Hooks, J. J. et al. Immune interferon in the circulation of patients with autoimmune disease. N. Engl. J. Med. 301, 5–8 (1979).
doi: 10.1056/NEJM197907053010102
Villani, A. C. et al. Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors. Science 356, eaah4573 (2017).
doi: 10.1126/science.aah4573
Ghebrehiwet, B., Hosszu, K. H. & Peerschke, E. I. C1q as an autocrine and paracrine regulator of cellular functions. Mol. Immunol. 84, 26–33 (2017).
doi: 10.1016/j.molimm.2016.11.003
Hulsebus, H. J., O’Conner, S. D., Smith, E. M., Jie, C. & Bohlson, S. S. Complement component C1q programs a pro-efferocytic phenotype while limiting TNFalpha production in primary mouse and human macrophages. Front. Immunol. 7, 230 (2016).
doi: 10.3389/fimmu.2016.00230
Ikezumi, Y. et al. The sialoadhesin (CD169) expressing a macrophage subset in human proliferative glomerulonephritis. Nephrol. Dial. Transplant. 20, 2704–2713 (2005).
doi: 10.1093/ndt/gfi105
Knutson, M. D. Iron transport proteins: gateways of cellular and systemic iron homeostasis. J. Biol. Chem. 292, 12735–12743 (2017).
doi: 10.1074/jbc.R117.786632
Adamson, S. E. et al. Disabled homolog 2 controls macrophage phenotypic polarization and adipose tissue inflammation. J. Clin. Invest. 126, 1311–1322 (2016).
doi: 10.1172/JCI79590
Spadaro, O. et al. IGF1 shapes macrophage activation in response to immunometabolic challenge. Cell Rep. 19, 225–234 (2017).
doi: 10.1016/j.celrep.2017.03.046
Varghese, B., Paulos, C. & Low, P. S. Optimization of folate-targeted immunotherapy for the treatment of experimental arthritis. Inflammation 39, 1345–1353 (2016).
doi: 10.1007/s10753-016-0366-7
Kreslavsky, T. et al. Essential role for the transcription factor Bhlhe41 in regulating the development, self-renewal and BCR repertoire of B-1a cells. Nat. Immunol. 18, 442–455 (2017).
doi: 10.1038/ni.3694
Angerer, P. et al. destiny: diffusion maps for large-scale single-cell data in R. Bioinformatics 32, 1241–1243 (2016).
doi: 10.1093/bioinformatics/btv715
van den Maaten, L. J. P. H. G. Visualizing high-dimensional data using t-SNE. J. Mach. Learn. Res. 9, 2579–2605 (2008).
Dehn, S. & Thorp, E. B. Myeloid receptor CD36 is required for early phagocytosis of myocardial infarcts and induction of Nr4a1-dependent mechanisms of cardiac repair. FASEB J. 32, 254–264 (2017).
doi: 10.1096/fj.201700450R
Bengsch, B. et al. Deep immune profiling by mass cytometry links human T and NK cell differentiation and cytotoxic molecule expression patterns. J. Immunol. Methods 453, 3–10 (2017).
doi: 10.1016/j.jim.2017.03.009
Bratke, K., Kuepper, M., Bade, B., Virchow, J. C. Jr. & Luttmann, W. Differential expression of human granzymes A, B, and K in natural killer cells and during CD8
doi: 10.1002/eji.200526122
Boddupalli, C. S. et al. ABC transporters and NR4A1 identify a quiescent subset of tissue-resident memory T cells. J. Clin. Invest. 126, 3905–3916 (2016).
doi: 10.1172/JCI85329
Mackay, L. K. et al. Hobit and Blimp1 instruct a universal transcriptional program of tissue residency in lymphocytes. Science 352, 459–463 (2016).
doi: 10.1126/science.aad2035
Allan, D. S. J. et al. Transcriptome analysis reveals similarities between human blood CD3(−) CD56(bright) cells and mouse CD127(+) innate lymphoid cells. Sci. Rep. 7, 3501 (2017).
doi: 10.1038/s41598-017-03256-0
McKinney, E. F., Lee, J. C., Jayne, D. R., Lyons, P. A. & Smith, K. G. T-cell exhaustion, co-stimulation and clinical outcome in autoimmunity and infection. Nature 523, 612–616 (2015).
doi: 10.1038/nature14468
Tilstra, J. S. et al. Kidney-infiltrating T cells in murine lupus nephritis are metabolically and functionally exhausted. J. Clin. Invest. 128, 4884–4897 (2018).
doi: 10.1172/JCI120859
Wherry, E. J. et al. Molecular signature of CD8
doi: 10.1016/j.immuni.2007.09.006
Nish, S. A. et al. CD4
doi: 10.1084/jem.20161046
Karnell, J. L. et al. Role of CD11c(+) T-bet(+) B cells in human health and disease. Cell. Immunol. 321, 40–45 (2017).
doi: 10.1016/j.cellimm.2017.05.008
Jenks, S. A. et al. Distinct effector B cells induced by unregulated Toll-like receptor 7 contribute to pathogenic responses in systemic lupus erythematosus. Immunity 49, 725–739.e6 (2018).
doi: 10.1016/j.immuni.2018.08.015
The FANTOM Consortium and the RIKEN PMI and CLST (DGT). A promoter-level mammalian expression atlas. Nature 507, 462–470 (2014).
Lizio, M. et al. Gateways to the FANTOM5 promoter level mammalian expression atlas. Genome Biol. 16, 22 (2015).
doi: 10.1186/s13059-014-0560-6
Wang, S. et al. IL-21 drives expansion and plasma cell differentiation of autoreactive CD11chiT-bet+ B cells in SLE. Nat. Commun. 9, 1758 (2018).
doi: 10.1038/s41467-018-03750-7
Chen, L., Morris, D. L. & Vyse, T. J. Genetic advances in systemic lupus erythematosus: an update. Curr. Opin. Rheumatol. 29, 423–433 (2017).
doi: 10.1097/BOR.0000000000000411
Chung, S. A. et al. Lupus nephritis susceptibility loci in women with systemic lupus erythematosus. J. Am. Soc. Nephrol. 25, 2859–2870 (2014).
doi: 10.1681/ASN.2013050446
Hua, Z. & Hou, B. TLR signaling in B-cell development and activation. Cell. Mol. Immunol. 10, 103–106 (2013).
doi: 10.1038/cmi.2012.61
Kawasaki, T. & Kawai, T. Toll-like receptor signaling pathways. Front. Immunol. 5, 461 (2014).
doi: 10.3389/fimmu.2014.00461
Madan-Lala, R. et al. Mycobacterium tuberculosis impairs dendritic cell functions through the serine hydrolase Hip1. J. Immunol. 192, 4263–4272 (2014).
doi: 10.4049/jimmunol.1303185
Matsuda, S. et al. Regulation of the cell cycle and inflammatory arthritis by the transcription cofactor LBH gene. J. Immunol. 199, 2316–2322 (2017).
doi: 10.4049/jimmunol.1700719
Botta, D. et al. Dynamic regulation of T follicular regulatory cell responses by interleukin 2 during influenza infection. Nat. Immunol. 18, 1249–1260 (2017).
doi: 10.1038/ni.3837
Wing, J. B. et al. A distinct subpopulation of CD25(−) T-follicular regulatory cells localizes in the germinal centers. Proc. Natl Acad. Sci. USA 114, E6400–e6409 (2017).
doi: 10.1073/pnas.1705551114
Winchester, R. et al. Immunologic characteristics of intrarenal T cells: trafficking of expanded CD8
doi: 10.1002/art.33488
Peterson, K. S. et al. Characterization of heterogeneity in the molecular pathogenesis of lupus nephritis from transcriptional profiles of laser-captured glomeruli. J. Clin. Invest. 113, 1722–1733 (2004).
doi: 10.1172/JCI200419139
Davidson, A. Editorial: autoimmunity to vimentin and lupus nephritis. Arthritis Rheumatol. 66, 3251–3254 (2014).
doi: 10.1002/art.38885
Myles, A., Gearhart, P. J. & Cancro, M. P. Signals that drive T-bet expression in B cells. Cell. Immunol. 321, 3–7 (2017).
doi: 10.1016/j.cellimm.2017.09.004
Huen, S. C. & Cantley, L. G. Macrophages in renal injury and repair. Ann. Rev. Physiol. 79, 449–469 (2017).
doi: 10.1146/annurev-physiol-022516-034219
Tabas, I. & Bornfeldt, K. E. Macrophage phenotype and function in different stages of atherosclerosis. Circ. Res. 118, 653–667 (2016).
doi: 10.1161/CIRCRESAHA.115.306256
Auffray, C. et al. Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior. Science 317, 666–670 (2007).
doi: 10.1126/science.1142883
Picelli, S. et al. Full-length RNA-seq from single cells using Smart-seq2. Nat. Protoc. 9, 171–181 (2014).
doi: 10.1038/nprot.2014.006
Nemesh, J. Drop-seq core computational protocol. McCarroll Laboratory http://mccarrolllab.com/wp-content/uploads/2016/03/Drop-seqAlignmentCookbookv1.2Jan2016.pdf (2016).
Satija, R., Farrell, J. A., Gennert, D., Schier, A. F. & Regev, A. Spatial reconstruction of single-cell gene expression data. Nat. Biotechnol. 33, 495–502 (2015).
doi: 10.1038/nbt.3192
McDavid, A. et al. Data exploration, quality control and testing in single-cell qPCR-based gene expression experiments. Bioinformatics 29, 461–467 (2013).
doi: 10.1093/bioinformatics/bts714
Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Statist. Soc. B 57, 289–300 (1995).
Tirosh, I. et al. Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq. Science 352, 189–196 (2016).
doi: 10.1126/science.aad0501
IUPHAR/BPS. Guide to Pharmacology. http://www.guidetopharmacology.org/download.jsp (2019).

Auteurs

Arnon Arazi (A)

Broad Institute of MIT and Harvard, Cambridge, MA, USA.

Deepak A Rao (DA)

Division of Rheumatology, Immunology, Allergy, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Celine C Berthier (CC)

Internal Medicine, Department of Nephrology, University of Michigan, Ann Arbor, MI, USA.

Anne Davidson (A)

Center for Autoimmune and Musculoskeletal Diseases, The Feinstein Institute for Medical Research, Northwell Health, Manhasset, NY, USA.

Yanyan Liu (Y)

Division of Rheumatology, Immunology, Allergy, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Paul J Hoover (PJ)

Broad Institute of MIT and Harvard, Cambridge, MA, USA.

Adam Chicoine (A)

Division of Rheumatology, Immunology, Allergy, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Thomas M Eisenhaure (TM)

Broad Institute of MIT and Harvard, Cambridge, MA, USA.

A Helena Jonsson (AH)

Division of Rheumatology, Immunology, Allergy, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Shuqiang Li (S)

Broad Institute of MIT and Harvard, Cambridge, MA, USA.

David J Lieb (DJ)

Broad Institute of MIT and Harvard, Cambridge, MA, USA.

Fan Zhang (F)

Division of Rheumatology, Immunology, Allergy, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Kamil Slowikowski (K)

Division of Rheumatology, Immunology, Allergy, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Edward P Browne (EP)

UNC HIV Cure Center and Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

Akiko Noma (A)

Broad Institute of MIT and Harvard, Cambridge, MA, USA.

Danielle Sutherby (D)

Celsius Therapeutics, Cambridge, MA, USA.

Scott Steelman (S)

Cellarity, Inc., Cambridge, MA, USA.

Dawn E Smilek (DE)

Lupus Nephritis Trials Network, University of California San Francisco, San Francisco, CA, USA.
Immune Tolerance Network, University of California San Francisco, San Francisco, CA, USA.

Patti Tosta (P)

Lupus Nephritis Trials Network, University of California San Francisco, San Francisco, CA, USA.
Immune Tolerance Network, University of California San Francisco, San Francisco, CA, USA.

William Apruzzese (W)

Division of Rheumatology, Immunology, Allergy, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Elena Massarotti (E)

Division of Rheumatology, Immunology, Allergy, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Maria Dall'Era (M)

Rheumatology Division, University of California San Francisco, San Francisco, CA, USA.

Meyeon Park (M)

Division of Nephrology, University of California San Francisco, San Francisco, CA, USA.

Diane L Kamen (DL)

Division of Rheumatology and Immunology, Medical University of South Carolina, Charleston, SC, USA.

Richard A Furie (RA)

Division of Rheumatology, Northwell Health, Great Neck, NY, USA.

Fernanda Payan-Schober (F)

Department of Medicine, Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center, El Paso, TX, USA.

William F Pendergraft (WF)

The Integrative Medical Clinic of North Carolina, PLLC, Chapel Hill, NC, USA.

Elizabeth A McInnis (EA)

University of North Carolina Kidney Center, Division of Nephrology and Hypertension, Department of Medicine, UNC School of Medicine, Chapel Hill, NC, USA.

Jill P Buyon (JP)

Department of Medicine, Division of Rheumatology, New York University School of Medicine, New York, NY, USA.

Michelle A Petri (MA)

Division of Rheumatology, Johns Hopkins University, Baltimore, MD, USA.

Chaim Putterman (C)

Division of Rheumatology and Department of Microbiology and Immunology, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY, USA.

Kenneth C Kalunian (KC)

University of California San Diego School of Medicine, La Jolla, CA, USA.

E Steve Woodle (ES)

Division of Transplantation, Department of Surgery, University of Cincinnati College of Medicine, Cincinnati, OH, USA.

James A Lederer (JA)

Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

David A Hildeman (DA)

Department of Pediatrics, University of Cincinnati, Cincinnati, OH, USA.
Division of Immunobiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.

Chad Nusbaum (C)

Cellarity, Inc., Cambridge, MA, USA.

Soumya Raychaudhuri (S)

Division of Rheumatology, Immunology, Allergy, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Matthias Kretzler (M)

Internal Medicine, Department of Nephrology, University of Michigan, Ann Arbor, MI, USA.

Jennifer H Anolik (JH)

Department of Medicine, Division of Allergy, Immunology, and Rheumatology, University of Rochester Medical Center, Rochester, NY, USA.

Michael B Brenner (MB)

Division of Rheumatology, Immunology, Allergy, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

David Wofsy (D)

Rheumatology Division, University of California San Francisco, San Francisco, CA, USA.

Nir Hacohen (N)

Broad Institute of MIT and Harvard, Cambridge, MA, USA. nhacohen@mgh.harvard.edu.

Betty Diamond (B)

Center for Autoimmune and Musculoskeletal Diseases, The Feinstein Institute for Medical Research, Northwell Health, Manhasset, NY, USA. BDiamond@northwell.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH